These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1930622)

  • 21. pH-Sensitive oral insulin delivery systems using Eudragit microspheres.
    Mundargi RC; Rangaswamy V; Aminabhavi TM
    Drug Dev Ind Pharm; 2011 Aug; 37(8):977-85. PubMed ID: 21417605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crystal growth formation in melt extrudates.
    Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
    Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation and in vitro evaluation of Eudragit microspheres containing acetazolamide.
    Haznedar S; Dortunç B
    Int J Pharm; 2004 Jan; 269(1):131-40. PubMed ID: 14698584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diclofenac sodium loaded gelatin magnetic microspheres for intra-arterial administration: formulation, characterization and in vitro release studies.
    Saravanan M; Bhaskar K; Narayanan NV; Maharajan G; Pillai KS
    Boll Chim Farm; 2003 Oct; 142(8):347-51. PubMed ID: 15040465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of enteric-coated fixed dose combinations of amorphous solid dispersions of ezetimibe and lovastatin: Investigation of formulation and process parameters.
    Riekes MK; Dereymaker A; Berben P; Augustijns P; Stulzer HK; Van den Mooter G
    Int J Pharm; 2017 Mar; 520(1-2):49-58. PubMed ID: 28153650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation and characteristics of microcapsules containing enoxacin by one continuous process of agglomeration and microencapsulation.
    Ueda M; Nakamura Y; Makita H; Kawashima Y
    J Microencapsul; 1993; 10(2):171-80. PubMed ID: 8331491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Controlled release of anticancer drug methotrexate from biodegradable gelatin microspheres.
    Narayani R; Rao KP
    J Microencapsul; 1994; 11(1):69-77. PubMed ID: 8138876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
    Sauer D; Zheng W; Coots LB; McGinity JW
    Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Permeability and swelling studies on free films containing inulin in combination with different polymethacrylates aimed for colonic drug delivery.
    Akhgari A; Farahmand F; Afrasiabi Garekani H; Sadeghi F; Vandamme TF
    Eur J Pharm Sci; 2006 Jul; 28(4):307-14. PubMed ID: 16713201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Naproxen-Eudragit microspheres: screening of process and formulation variables for the preparation of extended release tablets.
    Zaghloul AA; Faltinek J; Vaithiyalingam SR; Reddy IK; Khan MA
    Pharmazie; 2001 Apr; 56(4):321-4. PubMed ID: 11338673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alginate microspheres of isoniazid for oral sustained drug delivery.
    Rastogi R; Sultana Y; Aqil M; Ali A; Kumar S; Chuttani K; Mishra AK
    Int J Pharm; 2007 Apr; 334(1-2):71-7. PubMed ID: 17113732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between drug dissolution and leaching of plasticizer for pellets coated with an aqueous Eudragit S100:L100 dispersion.
    Bando H; McGinity JW
    Int J Pharm; 2006 Oct; 323(1-2):11-7. PubMed ID: 16815652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation and characterization of a powder containing an oily liquid drug with Eudragit EPO or L100 copolymer.
    Fujii M; Kawakami A; Saito A; Tuchiya H; Koizumi N; Watanabe Y
    Pharm Dev Technol; 2016 Dec; 21(8):1023-1028. PubMed ID: 26376360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Controlled release of D-glucose from starch granules containing 29% free D-glucose and Eudragit L100-55 as a binding and coating agent.
    Kim YK; Mukerjea R; Robyt JF
    Carbohydr Res; 2010 May; 345(8):1065-7. PubMed ID: 20381795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of the permeability characteristics of different polymethacrylates on the pharmaceutical characteristics of verapamil hyhdrochloride-loaded microspheres.
    Kiliçarslan M; Baykara T
    J Microencapsul; 2004 Mar; 21(2):175-89. PubMed ID: 15198429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microspheres with pH modulated release: design and characterization of formulation variables for colonic delivery.
    Chandran S; Sanjay KS; Ali Asghar LF
    J Microencapsul; 2009 Aug; 26(5):420-31. PubMed ID: 18821120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eudragit E, L and S (acrylic resins) microcapsules as pH sensitive release preparations of ketoprofen.
    Goto S; Kawata M; Nakamura M; Maekawa K; Aoyama T
    J Microencapsul; 1986; 3(4):305-16. PubMed ID: 3508191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An in-vitro-in-vivo taste assessment of bitter drug: comparative electronic tongues study.
    Maniruzzaman M; Douroumis D
    J Pharm Pharmacol; 2015 Jan; 67(1):43-55. PubMed ID: 25182780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of aluminum tristearate and sucrose stearate as the dispersing agents on physical properties and release characteristics of eudragit RS microspheres.
    iHoroz BB; Kliçarslan M; Yüksel N; Baykara T
    AAPS PharmSciTech; 2006 Feb; 7(1):E16. PubMed ID: 16584146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eudragit RL100 based microspheres for ocular administration of azelastine hydrochloride.
    Shinde UA; Shete JN; Nair HA; Singh KH
    J Microencapsul; 2012; 29(6):511-9. PubMed ID: 22375685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.